The storage lesions: From past to future;Les lésions de stockage : entre peurs rétrospectives et perspectives

Transfusion Clinique et Biologique

Volumn 24, Issue 3, 2017, Pages 277-284

  Tissot, J D ^a,b   Bardyn, M ^a   Sonego, G ^a   Abonnenc, M ^a   Prudent, M ^a,b  

^a Laboratoire de Recherche sur les Produits Sanguins   (Switzerland)

^b UNIVERSITY OF LAUSANNE   (Switzerland)

Author keywords

Ageing; Blood cells; Microparticles; Oxidation; Platelets; Proteomics; Red blood cells; Storage; Transfusion

Indexed keywords

AGING; AGITATION; BLOOD COMPONENT; BLOOD TRANSFUSION; CLINICAL TRIAL; ERYTHROCYTE CONCENTRATE; ERYTHROCYTE METABOLISM; FEMALE; HUMAN; MALE; OXIDATION; PROTEOMICS; STORAGE; THROMBOCYTE METABOLISM; TRANSFUSION MEDICINE; UNCERTAINTY; ANALOGS AND DERIVATIVES; BLOOD COMPONENT THERAPY; BLOOD STORAGE; CELL AGING; CLINICAL TRIAL (TOPIC); CYTOLOGY; ERYTHROCYTE; FORECASTING; LEUKAPHERESIS; METHODOLOGY; PROCEDURES; RETROSPECTIVE STUDY; TEMPERATURE; THROMBOCYTE; TRENDS;

ACID CITRATE DEXTROSE; CITRIC ACID; GLUCOSE; PRESERVATION SOLUTION;

BLOOD COMPONENT TRANSFUSION; BLOOD PLATELETS; BLOOD PRESERVATION; CELLULAR SENESCENCE; CITRIC ACID; CLINICAL TRIALS AS TOPIC; ERYTHROCYTES; FORECASTING; GLUCOSE; HUMANS; LEUKOCYTE REDUCTION PROCEDURES; ORGAN PRESERVATION SOLUTIONS; RESEARCH DESIGN; RETROSPECTIVE STUDIES; TEMPERATURE; TRANSFUSION MEDICINE;

EID: 85021663916     PISSN: 12467820     EISSN: 19538022     Source Type: Journal    
DOI: 10.1016/j.tracli.2017.05.012     Document Type: Short Survey

References (85)

1. Hoffmeister, K.M., Josefsson, E.C., Isaac, N.A., Clausen, H., Hartwig, J.H., et al. Glycosylation restores survival of chilled blood platelets. Science 301 (2003), 1531–1534.
2. Hoffmeister, K.M., Falet, H., Platelet clearance by the hepatic Ashwell-Morrell receptor: mechanisms and biological significance. Thromb Res 141 (2016), S68–S72.
3. Lee-Sundlov, M.M., Ashline, D.J., Hanneman, A.J., Grozovsky, R., Reinhold, V.N., et al. Circulating blood and platelets supply glycosyltransferases that enable extrinsic extracellular glycosylation. Glycobiology 27 (2017), 188–198.
4. Lefrancais, E., Ortiz-Munoz, G., Caudrillier, A., Mallavia, B., Liu, F., et al. The lung is a site of platelet biogenesis and a reservoir for haematopoietic progenitors. Nature 544 (2017), 105–109.
5. Howell, W.H., Donahue, D.D., The production of blood platelets in the lungs. J Exp Med 65 (1937), 177–203.
6. Garraud, O., Platelet components: is there need or room for quality control assays of storage lesions?. Blood Transfus, 2017, 10.2450/2016.0319-16.
7. Garraud, O., Cognasse, F., Tissot, J.D., Chavarin, P., Laperche, S., et al. Improving platelet transfusion safety: biomedical and technical considerations. Blood Transfus 14 (2016), 109–122.
8. Delobel, J., Garraud, O., Barelli, S., Lefrère, J.J., Prudent, M., et al. Storage lesion: history and perspectives. Worl J Hematol 4 (2015), 54–68.
9. Gibson, J.G. 2nd., Gregory, C.B., Button, L.N., Citrate-phosphate-dextrose solution for preservation of human blood: a further report. Transfusion 1 (1961), 280–287.
10. Bicalho, B., Serrano, K., Dos Santos Pereira, A., Devine, D.V., Acker, J.P., Blood bag plasticizers influence red blood cell vesiculation rate without altering the lipid composition of the vesicles. Transfus Med Hemother 43 (2016), 19–26.
11. Hogman, C.F., Hedlund, K., Zetterstrom, H., Clinical usefulness of red cells preserved in protein-poor mediums. N Engl J Med 299 (1978), 1377–1382.
12. D'Alessandro, A., Leucoreduction of blood components: clinical and molecular evidence. Blood Transfus 14 (2016), 212–213.
13. Abonnenc, M., Sonego, G., Kaiser-Guignard, J., Crettaz, D., Prudent, M., et al. In vitro evaluation of pathogen-inactivated buffy coat-derived platelet concentrates during storage: psoralen-based photochemical treatment step-by-step. Blood Transfus 13 (2015), 255–264.
14. Kaiser-Guignard, J., Canellini, G., Lion, N., Abonnenc, M., Osselaer, J.C., et al. The clinical and biological impact of new pathogen inactivation technologies on platelet concentrates. Blood Rev 28 (2014), 235–241.
15. Prowse, C.V., component pathogen inactivation: a critical review. Vox Sang. 104 (2013), 183–199.
16. Holcomb, J.B., Tilley, B.C., Baraniuk, S., Fox, E.E., Wade, C.E., et al. Transfusion of plasma, platelets, and red blood cells in a 1:1:1 vs a 1:1:2 ratio and mortality in patients with severe trauma: the PROPPR randomized clinical trial. JAMA 313 (2015), 471–482.
17. Bardyn, M., Rappaz, B., Jaferzadeh, K., Crettaz, D., Tissot, J.D., et al. Red blood cells ageing markers: a multi-parametric analysis. Blood Transfus 15 (2017), 239–248.
18. Blasi, B., D'Alessandro, A., Ramundo, N., Zolla, L., Red blood cell storage and cell morphology. Transfus Med 22 (2012), 90–96.
19. D'Alessandro, A., Kriebardis, A.G., Rinalducci, S., Antonelou, M.H., Hansen, K.C., et al. An update on red blood cell storage lesions, as gleaned through biochemistry and omics technologies. Transfusion 55 (2015), 205–219.
20. Hess, J.R., Red cell changes during storage. Transfus Apher Sci 43 (2010), 51–59.
21. D'Alessandro, A., Liumbruno, G., Grazzini, G., Zolla, L., Red blood cell storage: the story so far. Blood Transfus 8 (2010), 82–88.
22. D'Alessandro, A., Nemkov, T., Hansen, K.C., Szczepiorkowski, Z.M., Dumont, L.J., Red blood cell storage in additive solution-7 preserves energy and redox metabolism: a metabolomics approach. Transfusion 55 (2015), 2955–2966.
23. Prudent, M., Tissot, J.D., Lion, N., The 3-phase evolution of stored red blood cells and the clinical trials: an obvious relationship. Blood Transfus, 15, 2017, 188.
24. Rinalducci, S., Zolla, L., Biochemistry of storage lesions of red cell and platelet concentrates: a continuous fight implying oxidative/nitrosative/phosphorylative stress and signaling. Transfus Apher Sci 52 (2015), 262–269.
25. Kriebardis, A.G., Antonelou, M.H., Stamoulis, K.E., Economou-Petersen, E., Margaritis, L.H., et al. Progressive oxidation of cytoskeletal proteins and accumulation of denatured hemoglobin in stored red cells. J Cell Mol Med 11 (2007), 148–155.
26. Kriebardis, A.G., Antonelou, M.H., Stamoulis, K.E., Economou-Petersen, E., Margaritis, L.H., et al. Membrane protein carbonylation in non-leukodepleted CPDA-preserved red blood cells. Blood Cells Mol Dis 36 (2006), 279–282.
27. Prudent, M., Sonego, G., Abonnenc, M., Tissot, J.D., Lion, N., LC-MS/MS analysis and comparison of oxidative damages on peptides induced by pathogen reduction technologies for platelets. J Am Soc Mass Spectrom 25 (2014), 651–661.
28. Roussel, C., Dussiot, M., Marin, M., Morel, A., Ndour, P.A., Duez, J., et al. Spherocytic shift of red blood cells during storage provides a quantitative whole cell–based marker of the storage lesion. Transfusion 57 (2017), 1007–1018, 10.1111/trf.14015.
29. Delobel, J., Prudent, M., Crettaz, D., ElHajj, Z., Riederer, B.M., et al. Cysteine redox proteomics of the hemoglobin-depleted cytosolic fraction of stored red blood cells. Proteomics Clin Appl 10 (2016), 883–893.
30. Delobel, J., Prudent, M., Rubin, O., Crettaz, D., Tissot, J.D., et al. Subcellular fractionation of stored red blood cells reveals a compartment-based protein carbonylation evolution. J Proteomics 76 (2012), 181–193.
31. Prudent, M., Crettaz, D., Delobel, J., Seghatchian, J., et al. Differences between calcium-stimulated and storage-induced erythrocytes-derived microvesicles. Transfus. Apher. Sci. 53 (2015), 153–158.
32. Rubin, O., Delobel, J., Prudent, M., Lion, N., Kohl, K., et al. Red blood cell-derived microparticles isolated from blood units initiate and propagate thrombin generation. Transfusion 53 (2013), 1744–1754.
33. Rubin, O., Crettaz, D., Tissot, J.D., Lion, N., Pre-analytical and methodological challenges in red blood cell microparticle proteomics. Talanta 82 (2010), 1–8.
34. Rubin, O., Crettaz, D., Tissot, J.D., Lion, N., Microparticles in stored red blood cells: submicron clotting bombs?. Blood Transfus 8 (2010), s31–s38.
35. Rubin, O., Crettaz, D., Canellini, G., Tissot, J.D., Lion, N., Microparticles in stored red blood cells: an approach using flow cytometry and proteomic tools. Vox Sang 95 (2008), 288–297.
36. Tissot, J.D., Rubin, O., Canellini, G., Analysis and clinical relevance of microparticles from red blood cells. Curr Opin Hematol 17 (2010), 571–577.
37. Jy, W., Johansen, M.E., Bidot, C., Horstman, L.L., Ahn, Y.S., Red cell-derived microparticles (RMP) as haemostatic agent. Thromb. Haemost. 110 (2013), 751–760.
38. Prudent, M., D'Alessandro, A., Cazenave, J.P., Devine, D.V., Gachet, C., et al. Proteome changes in platelets after pathogen inactivation–an interlaboratory consensus. Transfus Med Rev 28 (2014), 72–83.
39. Nguyen, K.A., Chavarin, P., Arthaud, C.A., Cognasse, F., Garraud, O., Do manual and automated processes with distinct additive solutions affect whole blood-derived platelet components differently?. Blood Transfus 11 (2013), 152–153.
40. Abonnenc, M., Crettaz, D., Tacchini, P., Di Vincenzo, L., Sonego, G., et al. Antioxidant power as a quality control marker for completeness of amotosalen and ultraviolet A photochemical treatments in platelet concentrates and plasma units. Transfusion 56 (2016), 1819–1827.
41. Abonnenc, M., Sonego, G., Crettaz, D., Aliotta, A., Prudent, M., et al. In vitro study of platelet function confirms the contribution of the ultraviolet B (UVB) radiation in the lesions observed in riboflavin/UVB-treated platelet concentrates. Transfusion 55 (2015), 2219–2230.
42. Abonnenc, M., Crettaz, D., Marvin, L., Grund, B., Sonego, G., et al. Metabolomic profiling highlights oxidative damages in platelet concentrates treated for pathogen inactivation and shows protective role of urate. Metabolomics, 12, 2016, 188, 10.1007/s11306-016-1136-0.
43. Prudent, M., Tissot, J.D., Lion, N., In vitro assays and clinical trials in red blood cell aging: Lost in translation. Transfus Apher Sci 52 (2015), 270–276.
44. Zimring, J.C., Established and theoretical factors to consider in assessing the red cell storage lesion. Blood 125 (2015), 2185–2190.
45. Jordan, A., Chen, D., Yi, Q.L., Kanias, T., Gladwin, M.T., et al. Assessing the influence of component processing and donor characteristics on quality of red cell concentrates using quality control data. Vox Sang 111 (2016), 8–15.
46. Dern, R.J., Gwinn, R.P., Wiorkowski, J.J., Studies on the preservation of human blood. I. Variability in erythrocyte storage characteristics among healthy donors. J Lab Clin Med 67 (1966), 955–965.
47. Lacroix, J., Hebert, P.C., Fergusson, D.A., Tinmouth, A., Cook, D.J., et al. Age of transfused blood in critically ill adults. N Engl J Med 372 (2015), 1410–1418.
48. Garraud, O., Tissot, J.D., Vlaar, A.P., Short-term versus long-term blood storage. N Engl J Med, 376, 2017, 1091.
49. Heddle, N.M., Cook, R.J., Eikelboom, J.W., Short-term versus long-term blood storage. N Engl J Med 376 (2017), 1092–1093.
50. Jairath, V., Kahan, B.C., Gray, A., Dore, C.J., Mora, A., et al. Restrictive versus liberal blood transfusion for acute upper gastrointestinal bleeding (TRIGGER): a pragmatic, open-label, cluster randomised feasibility trial. Lancet 386 (2015), 137–144.
51. Spahn, D.R., Vamvakas, E.C., Is best transfusion practice alone best clinical practice?. Blood Transfus 11 (2013), 172–174.
52. Spahn, D.R., Shander, A., Hofmann, A., The chiasm: transfusion practice versus patient blood management. Best Pract Res Clin Anaesthesiol 27 (2013), 37–42.
53. Spahn, D.R., Goodnough, L.T., Alternatives to blood transfusion. Lancet 381 (2013), 1855–1865.
54. Zacharowski, K., Spahn, D.R., Patient blood management equals patient safety. Best Pract Res Clin Anaesthesiol 30 (2016), 159–169.
55. Spahn, D.R., Patient blood management: success and potential in the future. Ann Surg 264 (2016), 212–213.
56. Meybohm, P., Richards, T., Isbister, J., Hofmann, A., Shander, A., et al. Patient blood management bundles to facilitate implementation. Transfus Med Rev 31 (2017), 62–71.
57. Meybohm, P., Froessler, B., Goodnough, L.T., Klein, A.A., Munoz, M., et al. Simplified international recommendations for the implementation of patient blood management (SIR4PBM). Perioper Med (Lond), 6, 2017, 5.
58. Levy, J.H., Steiner, M.E., Transfusion, M., Hemostasis Clinical Trials, N., Clinical studies of erythrocyte outcomes and mortality: size really counts. Anesthesiology 118 (2013), 10–12.
59. Rahbar, M.H., Fox, E.E., del Junco, D.J., Cotton, B.A., Podbielski, J.M., et al. Coordination and management of multicenter clinical studies in trauma: experience from the Prospective Observational Multicenter Major Trauma Transfusion (PROMMTT) study. Resuscitation 83 (2012), 459–464.
60. Triulzi, D.J., Yazer, M.H., Clinical studies of the effect of blood storage on patient outcomes. Transfus Apher Sci 43 (2010), 95–106.
61. Vamvakas, E.C., Meta-analysis of clinical studies of the purported deleterious effects of “old” (versus “fresh”) red blood cells: are we at equipoise?. Transfusion 50 (2010), 600–610.
62. Heddle, N.M., Ness, P.M., CONSORT and clinical trial reporting: room for improvement. Transfusion 56 (2016), 781–783.
63. Cook, R.J., Heddle, N.M., Clinical trials evaluating pathogen-reduced platelet products: methodologic issues and recommendations. Transfusion 53 (2013), 1843–1855.
64. Sonego, G., Abonnenc, M., Tissot, J.D., Prudent, M., Lion, N., Redox proteomics and platelet activation: understanding the redox proteome to improve platelet quality for transfusion. Int J Mol Sci, 2017, 18.
65. Tudisco, C., Jett, B.W., Byrne, K., Oblitas, J., Leitman, S.F., et al. The value of pH as a quality control indicator for apheresis platelets. Transfusion 45 (2005), 773–778.
66. Germain, M., Gregoire, Y., Vassallo, R.R., Acker, J.P., Cardigan, R., et al. Quality control of apheresis platelets: a multicentre study to evaluate factors that can influence pH measurement. Vox Sang 112 (2017), 318–325.
67. Prudent, M., Crettaz, D., Delobel, J., Tissot, J.D., Lion, N., Proteomic analysis of Intercept-treated platelets. J Proteomics 76 (2012), 316–328.
68. Osman, A., Hitzler, W.E., Ameur, A., Provost, P., Differential expression analysis by RNA-Seq reveals perturbations in the platelet mRNA transcriptome triggered by pathogen reduction systems. PLoS One, 10, 2015, e0133070.
69. Osman, A., Hitzler, W.E., Meyer, C.U., Landry, P., Corduan, A., et al. Effects of pathogen reduction systems on platelet microRNAs, mRNAs, activation, and function. Platelets 26 (2015), 154–163.
70. Osman, A., Hitzler, W.E., Provost, P., Peculiarities of studying the effects of pathogen reduction technologies on platelets. Proteomics Clin Appl 10 (2016), 805–815.
71. Dahiya, N., Sarachana, T., Kulkarni, S., Wood Iii, W.H., Zhang, Y., et al. miR-570 interacts with mitochondrial ATPase subunit g (ATP5L) encoding mRNA in stored platelets. Platelets 28 (2017), 74–81.
72. Prudent, M., Tissot, J.D., Lion, N., Proteomics of blood and derived products: what's next?. Expert Rev Proteomics 8 (2011), 717–737.
73. Lion, N., Crettaz, D., Rubin, O., Tissot, J.D., Stored red blood cells: a changing universe waiting for its map(s). J Proteomics 73 (2010), 374–385.
74. Lion, N., Tissot, J.D., Application of proteomics to hematology: the revolution is starting. Expert Rev Proteomics 5 (2008), 375–379.
75. Thadikkaran, L., Siegenthaler, M.A., Crettaz, D., Queloz, P.A., Schneider, P., et al. Recent advances in blood-related proteomics. Proteomics 5 (2005), 3019–3034.
76. Tissot, J.D., Blood proteomics. J Proteomics 73 (2010), 466–467.
77. Tissot, J.D., Lion, N., The picture of Dorian Gray: news from the red blood cell storage lesion. Blood Transfus 12 (2014), 293–295.
78. Garraud, O., Tissot, J.D., Osselaer, J.C., Follea, G., Vernant, J.P., et al. Transfusion safety from the viewpoint of a musical quintet. Blood Transfus, 13, 2015, 687.
79. Moeremans, K., Warie, H., Annemans, L., Assessment of the economic value of the INTERCEPT blood system in Belgium. Transfus Med 16 (2006), 17–30.
80. Simon, M.S., Leff, J.A., Pandya, A., Cushing, M., Shaz, B.H., et al. Cost-effectiveness of blood donor screening for Babesia microti in endemic regions of the United States. Transfusion 54 (2014), 889–899.
81. McCullough, J., Goldfinger, D., Gorlin, J., Riley, W.J., Sandhu, H., et al. Cost implications of implementation of pathogen-inactivated platelets. Transfusion 55 (2015), 2312–2320.
82. Borkent-Raven, B.A., Janssen, M.P., van der Poel, C.L., Bonsel, G.J., van Hout, B.A., Cost-effectiveness of additional blood screening tests in the Netherlands. Transfusion 52 (2012), 478–488.
83. Marshall, D.A., Kleinman, S.H., Wong, J.B., AuBuchon, J.P., Grima, D.T., et al. Cost-effectiveness of nucleic acid test screening of volunteer blood donations for hepatitis B, hepatitis C and human immunodeficiency virus in the United States. Vox Sang 86 (2004), 28–40.
84. Rappaz, B., Barbul, A., Emery, Y., Korenstein, R., et al. Comparative study of human erythrocytes by digital holographic microscopy, confocal microscopy, and impedance volume analyzer. Cytometry Part A 73A (2008), 895–903.
85. Prudent, M., Rochat, B., Goffaux, G., Marvin, L., et al. Dynamic Metabolic Flux Analysis of Stored Red Blood Cells. Transfusion, 56, 2016 [25A–25A].